#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2658	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2216	346.4	0	.	n	.	0	A69G	SNP	69	69	A	282	282	G	356	G,A	226,65	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2658	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2216	346.4	0	.	n	.	0	C207T	SNP	207	207	C	420	420	T	345	T,C,A	120,152,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2658	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2216	346.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1663	1663	T	399	T,A	323,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2658	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2216	346.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1397	1397	C	401	C	325	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4234	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4018	315.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1917	1917	A	311	A	251	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4234	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4018	315.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2551	2551	C	414	C	331	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4234	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4018	315.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2625	2625	A	431	A	340	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4234	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4018	315.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3177	3177	C	370	C,G	282,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	330	folP	852	852	99.88	folP.l15.c4.ctg.1	2053	48.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1109	1111	AAA	74;74;74	A;A;A	61;60;58	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	330	folP	852	852	99.88	folP.l15.c4.ctg.1	2053	48.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1340	1342	AGC	70;70;69	A;G;C	52;56;54	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	882	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3519	74.3	1	SNP	p	S91F	0	.	.	271	273	TCC	632	634	TCC	63;63;63	T;C;C	51;56;54	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	882	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3519	74.3	1	SNP	p	D95N	0	.	.	283	285	GAC	644	646	GAC	63;64;64	G;A;C	52;53;51	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	882	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3519	74.3	1	SNP	p	D95G	0	.	.	283	285	GAC	644	646	GAC	63;64;64	G;A;C	52;53;51	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	318	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1615	59.0	1	SNP	p	G45D	0	.	.	133	135	GGC	601	603	GGC	88;88;88	G,A;G;C	71,1;73;73	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	166	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1179	41.5	0	.	n	.	0	A197.	DEL	197	197	A	640	640	A	76	A	58	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3138	106.8	1	SNP	p	D86N	0	.	.	256	258	GAC	656	658	GAC	131;131;131	G,A;A,T,G;C	106,1;99,1,1;108	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3138	106.8	1	SNP	p	S87I	0	.	.	259	261	AGT	659	661	AGT	131;134;134	A,C;G;T	101,1;107;106	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3138	106.8	1	SNP	p	S87R	0	.	.	259	261	AGT	659	661	AGT	131;134;134	A,C;G;T	101,1;107;106	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3138	106.8	1	SNP	p	S87W	0	.	.	259	261	AGT	659	661	AGT	131;134;134	A,C;G;T	101,1;107;106	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3138	106.8	1	SNP	p	S88P	0	.	.	262	264	TCC	662	664	TCC	134;136;136	T;C;C,A	108;106;105,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	684	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2889	70.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1665	1667	GGC	114;113;113	G,A;G;C	88,1;85;86	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1365	1367	GCA	98;99;99	G;C;A,C	73;79;76,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1368	1370	ATC	99;99;99	A;T,C,G;C	77;71,1,1;77	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1380	1382	GTG	99;98;97	G,A;T;G	73,1;74;74	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1380	1382	GTG	99;98;97	G,A;T;G	73,1;74;74	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1884	1886	ACC	67;67;67	A,C;C;C	53,1;55;55	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1938	1940	GCG	74;74;73	G;C,A;G	56;51,1;54	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1938	1940	GCG	74;74;73	G;C,A;G	56;51,1;54	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2061	2063	GGC	76;76;76	G;G,C;C,T	62;60,1;69,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2070	2072	GGC	74;74;74	G,A;G,T;C	58,1;58,1;66	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	602	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2624	68.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2088	2090	CTG	74;74;74	C,G;T,G;G	58,1;60,1;60	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	920	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3426	80.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1813	1815	CCG	87;87;87	C;C;G	70;70;69	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	428	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2258	56.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	784	784	C	59	C	48	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	531	533	GAA	85;85;85	G;A,C;A	73;70,1;74	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	819	821	GAT	95;95;95	G;A;T	77;70;72	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	942	944	TCA	99;99;99	T;C,G;A	77;75,1;80	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1071	1073	GTC	106;105;105	G;T;C	86;91;91	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1083	1085	TCT	101;100;100	T;C;T	79;84;85	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1401	1403	GCA	115;116;115	G,A;C;A	89,1;93;91	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	1	SNP	p	G120K	1	.	.	358	360	AAG	777	779	AAG	94;94;92	A;A;G	73;75;73	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	1	SNP	p	A121D	1	.	.	361	363	GAC	780	782	GAC	93;93;93	G;A,G;C	72;74,1;73	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	464	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1871	73.6	1	SNP	p	D121N	0	.	.	361	363	GAC	780	782	GAC	93;93;93	G;A,G;C	72;74,1;73	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1670	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5297	94.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2209	2211	AAT	93;94;94	A,C;A;T	71,1;77;73	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	258	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1399	55.2	1	SNP	p	V57M	1	.	.	169	171	ATG	828	830	ATG	112;112;113	A;T;G	92;88;91	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
